Value
7.9/10data confidence 83%| Component | Sub-score |
|---|---|
| P/E | 8.1 |
| P/S | 9.4 |
| Fwd P/E | 9.1 |
| PEG | 10.0 |
| Analyst target | 3.0 |
- ▸Forward P/E: 11.6x
- ▸PEG: 0.21
- ▸Attractively valued
MRX · Why this verdict
Why Marex Group (MRX) is rated SELL
Updated
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
VerdictSELL
Overall score6.3/10
ConfidenceMEDIUM
MacroNEUTRAL
TrendMatrix Research · core thesis
Engine thesis — one sentence
Marex Group has delivered 55% revenue growth, a perfect 4-quarter earnings beat streak, and a return on equity of 29%, but trades at or above its analyst price target with a technical breakout at 52-week highs and high leverage of 9.7x debt-to-equity limiting the margin of safety.
Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.
Thesis pillars
| Pillar | Expectation | Trend |
|---|---|---|
Marex Group grew revenue by 55% year-over-year and earns a return on equity of 29%, ranking as both a growth leader and return leader within its peer group in the capital markets industry, indicating strong execution in its financial intermediary business. Growth breakdown | Revenue growth remains above 25% year-over-year for the next 4 quarters, confirming that the 55% headline growth reflects sustainable business expansion rather than a one-time step-up. | →Stable |
| CounterCapital markets revenue is highly cyclical, and a 55% growth rate is unlikely to persist for multiple years — the key risk is that current estimates anchor to a peak activity environment. | ||
Marex has beaten earnings estimates in all 4 of the last 4 quarters with an average surprise of 7.5%, with the most recent quarter delivering a 7.1% beat of $1.48 actual versus $1.38 estimate, demonstrating consistent earnings delivery. Earnings | The earnings beat streak extends to 6 consecutive quarters with each result exceeding consensus by at least 5%, supporting the case that management is effectively guiding market expectations. | →Stable |
| CounterLight analyst coverage dampens the reliability of the signal, and a capital markets firm's earnings are sensitive to trading volumes and volatility that can shift rapidly. | ||
Debt-to-equity of 9.7x generates a leverage penalty, and with the stock at $62.50 — essentially at the analyst take-profit target of $62.44 — there is negative asymmetry, meaning the reward is virtually zero while the 7% downside risk remains fully present. Bear case | The stock price pulls back below $58 within 3 months, creating at least 7% upside to the resistance level before the next entry opportunity becomes attractive. | →Stable |
| CounterFinancial firms typically operate with high leverage as a structural feature, not a risk indicator, and a 9.7x debt-to-equity in capital markets may reflect normal balance sheet construction rather than elevated financial risk. | ||
Marex is in a confirmed breakout setup — golden cross, above all moving averages, RSI at 70, MACD bullish — with the stock within 1.9% of its 52-week high and rising on-balance volume showing institutional accumulation. Momentum breakdown | The stock achieves a new 52-week high above $65 within 3 months, confirming that the breakout has follow-through and that technical momentum can sustain the current valuation level. | →Stable |
| CounterAt RSI 70, the stock is approaching overbought territory, and trading at or above the analyst price target at a 52-week high creates a scenario where any negative surprise could trigger a sharp reversal. | ||
Marex Group grew revenue by 55% year-over-year and earns a return on equity of 29%, ranking as both a growth leader and return leader within its peer group in the capital markets industry, indicating strong execution in its financial intermediary business.
→StableGrowth breakdown
- Expectation
- Revenue growth remains above 25% year-over-year for the next 4 quarters, confirming that the 55% headline growth reflects sustainable business expansion rather than a one-time step-up.
CounterCapital markets revenue is highly cyclical, and a 55% growth rate is unlikely to persist for multiple years — the key risk is that current estimates anchor to a peak activity environment.
Marex has beaten earnings estimates in all 4 of the last 4 quarters with an average surprise of 7.5%, with the most recent quarter delivering a 7.1% beat of $1.48 actual versus $1.38 estimate, demonstrating consistent earnings delivery.
→StableEarnings
- Expectation
- The earnings beat streak extends to 6 consecutive quarters with each result exceeding consensus by at least 5%, supporting the case that management is effectively guiding market expectations.
CounterLight analyst coverage dampens the reliability of the signal, and a capital markets firm's earnings are sensitive to trading volumes and volatility that can shift rapidly.
Debt-to-equity of 9.7x generates a leverage penalty, and with the stock at $62.50 — essentially at the analyst take-profit target of $62.44 — there is negative asymmetry, meaning the reward is virtually zero while the 7% downside risk remains fully present.
→StableBear case
- Expectation
- The stock price pulls back below $58 within 3 months, creating at least 7% upside to the resistance level before the next entry opportunity becomes attractive.
CounterFinancial firms typically operate with high leverage as a structural feature, not a risk indicator, and a 9.7x debt-to-equity in capital markets may reflect normal balance sheet construction rather than elevated financial risk.
Marex is in a confirmed breakout setup — golden cross, above all moving averages, RSI at 70, MACD bullish — with the stock within 1.9% of its 52-week high and rising on-balance volume showing institutional accumulation.
→StableMomentum breakdown
- Expectation
- The stock achieves a new 52-week high above $65 within 3 months, confirming that the breakout has follow-through and that technical momentum can sustain the current valuation level.
CounterAt RSI 70, the stock is approaching overbought territory, and trading at or above the analyst price target at a 52-week high creates a scenario where any negative surprise could trigger a sharp reversal.
Per-dimension breakdown
Quality
6.2/10data confidence 100%| Component | Sub-score |
|---|---|
| ROE | 9.7 |
| ROA | 0.8 |
| Gross margin | 9.8 |
| Op margin | 5.2 |
| Net margin | 5.3 |
| Current ratio | 4.2 |
| Moat | 7.5 |
| Piotroski F | 6.7 |
- ▸Excellent ROE: 29%
- ▸Wide economic moat
- ▸Compounder quality: strong returns + growth
Growth
10.0/10data confidence 67%| Component | Sub-score |
|---|---|
| Rev growth | 10.0 |
| EPS growth | 10.0 |
- ▸Strong growth: 55% YoY
Momentum
6.6/10data confidence 100%| Component | Sub-score |
|---|---|
| RSI | 4.1 |
| MACD | 10.0 |
| OBV | 10.0 |
| MA position | 9.0 |
| Volume | 0.0 |
- ▸Overbought (RSI 78)
- ▸Volume accumulation (rising OBV)
- ▸Above 200-day MA
Sentiment
4.5/10data confidence 100%| Component | Sub-score |
|---|---|
| Analyst rating | 5.0 |
| Price target | 3.5 |
| erm sentiment | 5.0 |
- ▸Below analyst target
Insider
3.4/10data confidence 75%| Component | Sub-score |
|---|---|
| materiality | 3.0 |
| insider conviction | 2.0 |
| holder change | 5.1 |
- ▸Notable insider selling — $7,874,621 (0.169% of mkt cap)
Peer rank
5.3/10data confidence 80%| Component | Sub-score |
|---|---|
| value rank | 7.1 |
| quality rank | 6.2 |
| growth rank | 8.1 |
- ▸Superior ROE vs peers
- ▸Industry growth leader
Technical
4.3/10data confidence 100%| Component | Sub-score |
|---|---|
| bollinger | 2.3 |
| support resistance | 1.3 |
| 52w position | 9.3 |
Risk (lower is worse)
4.2/10data confidence 100%| Component | Sub-score |
|---|---|
| short interest | 7.7 |
| days to cover | 7.4 |
| volatility | 1.7 |
| put call | 5.3 |
| implied vol | 4.4 |
| max pain risk | 3.0 |
| debt equity | 0.0 |
- ▸Above max pain $45
Catalyst
6.5/10data confidence 100%| Component | Sub-score |
|---|---|
| erm | 5.0 |
| earnings history | 10.0 |
| earnings timing | 5.0 |
| surprise avg | 6.3 |
| dividend safety | 6.0 |
- ▸Perfect beat streak: 4Q
- ▸Dividend: 99.0%
How the verdict was assembled
Engine trigger
Multiple concerning factors. Consider reducing position.
Engine technical detail
verdict_path:
L4:PATH_F_SELLPassed (7)
- MOMENTUM:6.6>=5.5
- INSIDER:OK
- 8K:CLEAN
- NEWS_EVENTS:NONE_RECENT
- EARNINGS_PROXIMITY:47d clear
- SEMI_CYCLE_PEAK:CLEAR
- MATERIALS_CYCLE_PEAK:CLEAR
Failed (1)
- ASYMMETRY:-1.5=NEGATIVE
Warning (0)
none
Reward-to-Risk
-1.48
Upside
-22.3%
Downside
15.0%
Sizing output
AVOID
SetupUNKNOWN — No clear chart pattern; technical signals are mixed
EdgeNO_EDGE — No clear edge identified
SuitabilityAGGRESSIVE — MCap $4.7B<$5B
Investment implication
The F-path SELL output reflects an overall score of 4.8 below the 5.6 soft trigger — multiple weakening dimensions accumulated rather than a single hard-floor breach. The strongest dimension ( Growth at 10.0) was not enough to lift the adjusted overall above the threshold. Co-occurring failed gates ( ASYMMETRY:-1.5=NEGATIVE) reinforce the read. Current asymmetry R:R is -1.48 — supplementary context, not the trigger for this path.
The strongest dimensions are Growth at 10.0, Value at 7.9, and Momentum at 6.6; the weakest are Insider at 3.4, Risk (lower is worse) at 4.2, and Technical at 4.3. The V9 engine flagged 1 failed gate, producing an asymmetric reward-to-risk of -1.48 and an engine sizing output of AVOID.
What would invalidate the thesis
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
- P1Marex Group grew revenue by 55% year-over-year and earns a return on equity of 29%, ranking as both a growth leader and return leader within its peer group in the capital markets industry, indicating strong execution in its financial intermediary business.
Trip ifRevenue growth falls below 15% year-over-year for 2 consecutive quarters, indicating that the 55% growth rate is decelerating faster than expected.
- P2Marex has beaten earnings estimates in all 4 of the last 4 quarters with an average surprise of 7.5%, with the most recent quarter delivering a 7.1% beat of $1.48 actual versus $1.38 estimate, demonstrating consistent earnings delivery.
Trip ifEarnings miss by more than 8% in any 1 of the next 2 quarters, breaking the 4-quarter consecutive beat streak.
- P3Debt-to-equity of 9.7x generates a leverage penalty, and with the stock at $62.50 — essentially at the analyst take-profit target of $62.44 — there is negative asymmetry, meaning the reward is virtually zero while the 7% downside risk remains fully present.
Trip ifDebt-to-equity ratio rises above 12x or the stock price falls below $55, representing more than 12% downside from current levels.
- P4Marex is in a confirmed breakout setup — golden cross, above all moving averages, RSI at 70, MACD bullish — with the stock within 1.9% of its 52-week high and rising on-balance volume showing institutional accumulation.
Trip ifThe stock price falls below the 200-day moving average and RSI declines below 40, indicating the breakout has reversed into a confirmed downtrend.